Hiroki Shimizu

1.2k total citations
92 papers, 857 citations indexed

About

Hiroki Shimizu is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Hiroki Shimizu has authored 92 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 35 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Hiroki Shimizu's work include Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Surgical Treatments (10 papers) and MicroRNA in disease regulation (10 papers). Hiroki Shimizu is often cited by papers focused on Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Surgical Treatments (10 papers) and MicroRNA in disease regulation (10 papers). Hiroki Shimizu collaborates with scholars based in Japan, United States and Canada. Hiroki Shimizu's co-authors include Eigo Otsuji, Atsushi Shiozaki, Kazuma Okamoto, Hitoshi Fujiwara, Daisuke Ichikawa, Shuhei Komatsu, Hirotaka Konishi, Takeshi Kubota, Toshiyuki Kosuga and Tomohiro Arita and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and American Journal Of Pathology.

In The Last Decade

Hiroki Shimizu

86 papers receiving 848 citations

Peers

Hiroki Shimizu

SURGE

ONCOL

PRM

Noritaka Minagawa Japan

Ivonne Regel Germany

Lushun Yuan China

Song He China

Carlo Ganini Italy

Guillermo Pita Spain

Koji Miyagawa Japan

Yuanfeng Gong China

Jianbin Bi China

Junhui Yu China

Noritaka Minagawa Japan

Hiroki Shimizu

372 ×1.0

238 ×0.9

SURGE

344 ×1.4

ONCOL

120 ×0.6

PRM

125 ×0.7

Citations per year, relative to Hiroki Shimizu Hiroki Shimizu (= 1×) peers Noritaka Minagawa

Countries citing papers authored by Hiroki Shimizu

Since Specialization

Citations

This map shows the geographic impact of Hiroki Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Shimizu more than expected).

Fields of papers citing papers by Hiroki Shimizu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Shimizu. The network helps show where Hiroki Shimizu may publish in the future.

Co-authorship network of co-authors of Hiroki Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Shimizu. A scholar is included among the top collaborators of Hiroki Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Shimizu. Hiroki Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamamoto, Yusuke, Taisuke Imamura, Hisashi Ikoma, et al.. (2025). Development of IKOMAP Formulas for Determining Appropriate Liver Transection Line in Ultrasound‐Guided Minimally Invasive Partial Hepatectomy Considering Liver Inclination. Journal of Hepato-Biliary-Pancreatic Sciences. 32(10). 734–744. 1 indexed citations

Inoue, Hiroyuki, Hiroki Shimizu, Yoshiaki Kuriu, et al.. (2024). Patients with T4N0 and T1‑3N1 colon cancer and a high preoperative carcinoembryonic antigen level benefit from adjuvant chemotherapy with oxaliplatin for 6 months. Oncology Letters. 29(1). 13–13.

Inoue, Hiroyuki, Atsushi Shiozaki, Toshiyuki Kosuga, et al.. (2024). CACNA2D1 regulates the progression and influences the microenvironment of colon cancer. Journal of Gastroenterology. 59(7). 556–571. 4 indexed citations

Yamamoto, Atsushi, Hiroki Shimizu, Katsutoshi Shoda, et al.. (2024). The Expression and Role of Aquaporin 4 in Colon Cancer. Anticancer Research. 44(2). 567–573. 1 indexed citations

Arita, Tomohiro, Hirotaka Konishi, Satoshi Kataoka, et al.. (2023). Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition. Genes. 14(7). 1414–1414. 7 indexed citations

Shiozaki, Atsushi, Hiroki Shimizu, Toshiyuki Kosuga, et al.. (2023). Effects of TRPV2 on the Expression of PD-L1 and Its Binding Ability to PD-1 in Gastric Cancer. Annals of Surgical Oncology. 30(13). 8704–8716. 2 indexed citations

Shiozaki, Atsushi, Hiroyuki Inoue, Hiroki Shimizu, et al.. (2023). Cancer Stem Cells of Esophageal Adenocarcinoma are Suppressed by Inhibitors of TRPV2 and SLC12A2. Annals of Surgical Oncology. 30(13). 8743–8754. 1 indexed citations

Shimizu, Hiroki, Katsutoshi Shoda, Kensuke Shiraishi, et al.. (2023). The Expression and Role of NADPH Oxidase 2 in Colon Cancer. Anticancer Research. 43(6). 2601–2608. 1 indexed citations

Inoue, Hiroyuki, Atsushi Shiozaki, Toshiyuki Kosuga, et al.. (2022). Functions and Clinical Significance of CACNA2D1 in Gastric Cancer. Annals of Surgical Oncology. 29(7). 4522–4535. 11 indexed citations

10.

Inoue, Hiroyuki, Tsutomu Kawaguchi, Hisashi Ikoma, et al.. (2021). Oligometastasis scoring system for predicting survival of patients with colorectal liver metastasis after hepatectomy. Journal of Surgical Oncology. 124(5). 791–800. 1 indexed citations

11.

Shiozaki, Atsushi, Toshiyuki Kosuga, Hiroki Shimizu, et al.. (2021). ANO9 regulates PD‐L2 expression and binding ability to PD‐1 in gastric cancer. Cancer Science. 112(3). 1026–1037. 11 indexed citations

12.

Shiozaki, Atsushi, Michihiro Kudou, Hiroki Shimizu, et al.. (2021). LRRC8A influences the growth of gastric cancer cells via the p53 signaling pathway. Gastric Cancer. 24(5). 1063–1075. 25 indexed citations

13.

Sugihara, Junichi, Hiroki Shimizu, Yun‐Yan Xiang, et al.. (2021). Pathogenesis of Multinodular Goiter in Elderly XB130-Deficient Mice: Alteration of Thyroperoxidase Affinity with Iodide and Hydrogen Peroxide. Thyroid. 32(4). 385–396. 2 indexed citations

14.

Wang, Yingchun, Hiroki Shimizu, Yun‐Yan Xiang, et al.. (2021). XB130 Deficiency Causes Congenital Hypothyroidism in Mice due to Disorganized Apical Membrane Structure and Function of Thyrocytes. Thyroid. 31(11). 1650–1661. 6 indexed citations

15.

Konishi, Hirotaka, Katsutoshi Shoda, Tomohiro Arita, et al.. (2021). Significance of Plasma UCA1 for Predicting Colorectal Cancer and BRAF Mutation Status. Anticancer Research. 41(4). 1761–1769. 3 indexed citations

16.

Shiozaki, Atsushi, Michihiro Kudou, Hitoshi Fujiwara, et al.. (2020). Clinical safety and efficacy of neoadjuvant combination chemotherapy of tranilast in advanced esophageal squamous cell carcinoma. Medicine. 99(50). e23633–e23633. 13 indexed citations

17.

Ashizawa, Naoki, Hiroki Shimizu, Makoto Sudo, et al.. (2019). Clinical Significance of NADPH Oxidase 5 in Human Colon Cancer. Anticancer Research. 39(8). 4405–4410. 5 indexed citations

18.

Hirayama, Kazuyoshi, Hiroki Shimizu, Shinji Furuya, et al.. (2018). Clinical Impact of Histological Heterogeneity in the Metastatic Lymph Nodes of Patients with Colorectal Cancer. Anticancer Research. 38(8). 4797–4803. 2 indexed citations

19.

Shiozaki, Atsushi, Daisuke Ichikawa, Kenichi Takemoto, et al.. (2014). Efficacy of a Hypotonic Treatment for Peritoneal Dissemination from Gastric Cancer Cells: AnIn VivoEvaluation. BioMed Research International. 2014. 1–8. 10 indexed citations

20.

Shiozaki, Atsushi, Daisuke Iitaka, Daisuke Ichikawa, et al.. (2013). xCT, component of cysteine/glutamate transporter, as an independent prognostic factor in human esophageal squamous cell carcinoma. Journal of Gastroenterology. 49(5). 853–863. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact